CBER Director Peter Marks (Greg Nash/Pool via AP Images)
April 18, 2023 02:57 PM EDT
Pharma
FDA+
Coronavirus

FDA sim­pli­fies Covid-19 bi­va­lent vac­ci­na­tion process ahead of June ad­comm

Paul Schloesser

Associate Editor

The FDA is mod­i­fy­ing the emer­gency use au­tho­riza­tion for Mod­er­na and Pfiz­er/BioN­Tech’s Covid-19 vac­cines by re­mov­ing the two-dose pri­ma­ry se­ries (ex­cept for chil­dren) and the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

A service from the Financial Times